U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes

Hemolysis is a well-recognized but poorly characterized phenomenon in a subset of patients with myelodysplastic syndromes (MDS). Its pathobiological basis seems to underpin a nonimmune etiology whose clinical significance has not been adequately characterized. Hemolysis in MDS is often attributed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Komrokji, Rami, Aguirre, Luis E., Al Ali, Najla, Hussaini, Mohamad, Sallman, David, Rollison, Dana, Padron, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813529/
https://www.ncbi.nlm.nih.gov/pubmed/36129843
http://dx.doi.org/10.1182/bloodadvances.2022007504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813529/
https://www.ncbi.nlm.nih.gov/pubmed/36129843
http://dx.doi.org/10.1182/bloodadvances.2022007504

Ejemplares similares